RxDoctor Payments Data

Charles Higgins, MD

Psychiatry · New Orleans, LANPI 1932476199

Payments from drug & device makers

$4,665in general payments, 2019–2025

Across 344 payments — averaging $13.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$889
  • Corium, LLC$764
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$417
  • Lundbeck LLC$361
  • Alkermes, Inc.$285
  • plus $909 from 16 others

What the payments were for

  • Food & beverage$4,56798%
  • Education$972%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,665 in reported general payments places this provider in the 85th percentile of 474 psychiatry providers in Louisiana.

See all psychiatry providers in Louisiana

Medicare billing

Part B allowed, 2024
$12,685
Medicare patients
60
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate11$44,087
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl20$3,045
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine36$1,169
Alprazolam OdtAlprazolam13$1,077
Fluoxetine Hcl61$675
Venlafaxine Hcl ErVenlafaxine Hcl22$584
Quetiapine Fumarate52$477
Mirtazapine17$382
Alprazolam81$377
Divalproex Sodium15$374
Bupropion XlBupropion Hcl20$259
Olanzapine24$254
Aripiprazole21$240
Clonazepam37$235
Propranolol Hcl25$226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$146$44,08711 claims
Almatica Pharma LLCSertraline Hcl$18$11322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 474 psychiatry providers in Louisiana.

Other psychiatry in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →